Home LiteratureArticle Details
PMID: 10503903 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Chemoprevention of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine-induced mammary carcinogenesis in rats.

Cancer letters ·Vol. 143 ·No. 2 ·1999-09-01 ·Pages 195-8

Mori H, Sugie S, Rahman W, Suzui N

Abstract

Modifying effects of dietary exposure of diallyl disulfide (DAD), aspirin, DL-alpha-difluoromethylomithine (DFMO), beta-naphthoflavone (beta-NF), alpha-naphthoflavone (alpha-NF), indole-3-carbinol (I3C) and protocatechuic acid (PCA) on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis were examined in two experiments with female rats. For both experiments, PhIP in corn oil at a concentration of 85 mg/kg was given to animals via an intragastric tube for eight doses for an initial 4 weeks, and test chemicals were given in the diet (Experiment 1: DAD, 200 ppm; aspirin, 400 ppm; DFMO, 400 ppm; beta-NF, 1000 ppm; Experiment 2: alpha-NF, 1000 ppm; I3C, 1000 ppm; PCA, 2000 ppm) for an initial 4 weeks. The experiments were terminated after 25 weeks. In Experiment 1, exposure of beta-NF decreased the incidence and multiplicity of total mammary tumors (fibroadenoma, intraductal carcinoma and invasive ductal carcinoma) (P < 0.001 and P < 0.0001), and lowered the incidence of ductal carcinoma (P < 0.0001). DAD lowered the incidence of ductal carcinoma and decreased the multiplicity of the total tumors (P < 0.01 and P < 0.005). Furthermore, aspirin decreased the total tumors (P < 0.05). In Experiment 2, alpha-NF decreased the multiplicity of ductal carcinoma (P < 0.05). These results suggest that alpha-NF, beta-NF, DAD or aspirin could be chemopreventing agents for mammary neoplasia.

MeSH Terms
Allyl Compounds/pharmacology,therapeutic use Animals Anticarcinogenic Agents/pharmacology,therapeutic use Aspirin/pharmacology,therapeutic use Benzoflavones/pharmacology,therapeutic use Carcinogens/administration & dosage,toxicity Disulfides/pharmacology,therapeutic use Drug Antagonism Eflornithine/pharmacology,therapeutic use Female Hydroxybenzoates/pharmacology,therapeutic use Imidazoles/administration & dosage,toxicity Indoles/pharmacology,therapeutic use Mammary Neoplasms, Experimental/chemically induced,prevention & control Rats Rats, Sprague-Dawley beta-Naphthoflavone/pharmacology,therapeutic use
Chemicals
Allyl Compounds Anticarcinogenic Agents Benzoflavones Carcinogens Disulfides Hydroxybenzoates Imidazoles Indoles protocatechuic acid diallyl disulfide alpha-naphthoflavone beta-Naphthoflavone 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine indole-3-carbinol Aspirin Eflornithine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Mori H
Department of Pathology, Gifu University School of Medicine, Japan.
Sugie S
Rahman W
Suzui N
Article Info
Journal
Cancer letters
Abbr.
Cancer Lett
ISSN
0304-3835
Published
1999-09-01
Pages
195-8
Language
English
Region
Ireland
NLM ID
7600053
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com